Medicine Supply Notification: Rifadin (rifampicin) 100mg/5ml oral suspension (Sanofi)

Medicine Supply Notification: Rifadin (rifampicin) 100mg/5ml oral suspension (Sanofi)

December 3, 2020

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Rifadin (rifampicin) 100mg/5ml oral suspension (Sanofi)

Sanofi have limited supplies of Rifadin 100mg/5ml oral suspension with resupply expected w/c 18 January 2021

Until 18 January 2021, supplies will only remain available to primary care, where demand exceeds the historic use for a pharmacy a prescription validation process will be implemented. Anonymised prescriptions will need to be sent via email to Sanofi Customer Services  to receive further supplies.

Unlicensed imports of Rifadin 100mg/5ml oral suspension have been sourced, leads times may vary.

The following specialist importers have confirmed they can source unlicensed Rifadin 100mg/5ml oral suspension (please note there may be other companies that can also source supplies):

The following Specials manufacturers have confirmed they can supply unlicensed rifampicin 100mg/5ml oral suspension (please note there may be other companies that can also manufacture this presentation)

There is currently no listing on dm+d for the imported or unlicensed products for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Rifampicin 100mg/5ml orals suspension cannot be issued. Where a prescriber wishes to prescribe an unlicensed import or specially manaufactured product, an FP10 paper prescription should be issued as Rifampicin 100mg/5ml oral suspension (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.


Posted in: ,

More Latest News >

Have you completed the DMS DoC?

Pharmacists and pharmacy technicians are reminded that they must complete the Discharge Medicines Service (DMS) Declaration of Competence (DoC) before...

FAQs on the HEE workforce survey

The 2021 Health Education England (HEE) Community Pharmacy Workforce Survey commenced today. PSNC encourages all pharmacy contractors to participate in...

April CPN magazine published

The April 2021 edition of PSNC’s Community Pharmacy News (CPN) is now available. This issue of CPN features: Negotiations begin...